Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this ...

Five high-yield names spanning pharmaceuticals, consumer staples, energy, and ETFs offer income investors compelling yields ...

Looking for the latest stock opportunities in June 2026? We have you covered. Click to read our top stock picks to consider ...

From Eli Lilly's David Ricks to Pfizer's Albert Bourla, the top five highest paid CEOs made a combined $157.8 million in 2025 ...

President Donald Trump on Monday announced more than 600 drugs added to his signature drug coupon platform TrumpRx, ...

Tuesday, May 12, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp.

Imagine you are sick with a serious medical condition. How would you feel if someone constantly told you to buy their product ...

Minnesota's 340B drug discount program faces scrutiny as small clinics struggle and large hospitals profit, sparking ...

In a budget dominated by cost-of-living pressures and global instability, the Federal Government has unveiled a major multi-billion-dollar investment into Australia’s healthcare system. Medicare ...

Eli Lilly's Mounjaro has overtaken Keytruda to become the world's top-selling medicine. Its rise highlights booming demand for obesity and diabetes therapies globally and in India.

By forcing companies to spend much of their paid advertising time mentioning all risks and opening them up to lawsuits, ...

The ETHIC Act is an important first step for pruning patent thickets and curbing the endless litigation that keeps lower-cost drugs off the shelf.